Real-world effectiveness and treatment costs of ceftazidime–avibactam versus colistin–meropenem for ICU-acquired MDR gram-negative infections in liver transplant recipients

This publication has 30 references indexed in Scilit:

• Comparison of ceftazidime-avibactam with other appropriate antimicrobial therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections in Türkiye: A multi-centre retrospective matched-cohort study
  International Journal of Antimicrobial Agents, 2025
• Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation
  Infectious Diseases and Therapy, 2025
• Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia
  The Brazilian Journal of Infectious Diseases, 2025
• Carbapenem-resistant Enterobacterales in solid organ transplant recipients
  American Journal of Transplantation, 2024
• EASL Clinical Practice Guidelines on liver transplantation
  Journal of Hepatology, 2024
• Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis
  Infectious Diseases and Therapy, 2024
• Efficacy of ceftazidime-avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infections: Focus on solid organ transplantation recipients
  International Journal of Antimicrobial Agents, 2024
• Ceftazidime–avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis
  Infection, 2023
• Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae
  American Journal of Transplantation, 2023
• International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019